Heat‐ and anesthesia‐induced malignant hyperthermia in an RyR1 knock‐in mouse
- 11 November 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 20 (2) , 329-330
- https://doi.org/10.1096/fj.05-4497fje
Abstract
Malignant hyperthermia (MH) is a life-threatening disorder characterized by skeletal muscle rigidity and elevated body temperature in response to halogenated anesthetics such as isoflurane or halothane. Mutation of tyrosine 522 of RyR1 (the predominant skeletal muscle calcium release channel) to serine has been associated with human malignant hyperthermia. In the present study, mice created harboring this mutation were found to represent the first murine model of human malignant hyperthermia. Mice homozygous for the Y522S mutation exhibit skeletal defects and die during embryonic development or soon after birth. Heterozygous mice, which correspond to the human occurrence of this mutation, are MH susceptible, experiencing whole body contractions and elevated core temperatures in response to isoflurane exposure or heat stress. Skeletal muscles from heterozygous mice exhibit increased susceptibility to caffeine- and heat-induced contractures in vitro. In addition, the heterozygous expression of the mutation results in enhanced RyR1 sensitivity to activation by temperature, caffeine, and voltage but not uncompensated sarcoplasmic reticulum calcium leak or store depletion. We conclude that the heterozygous expression of the Y522S mutation confers susceptibility to both heat- and anesthetic-induced MH responses.Keywords
Funding Information
- National Institutes of Health (AR41802 and AR44864)
This publication has 28 references indexed in Scilit:
- Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involvedCell Calcium, 2005
- Distinct Effects on Ca2+ Handling Caused by Malignant Hyperthermia and Central Core Disease Mutations in RyR1Biophysical Journal, 2004
- The Pore Region of the Skeletal Muscle Ryanodine Receptor Is a Primary Locus for Excitation-Contraction Uncoupling in Central Core DiseaseThe Journal of general physiology, 2003
- A recessive form of central core disease, transiently presenting as multi‐minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 geneAnnals of Neurology, 2002
- Functional Effects of Central Core Disease Mutations in the Cytoplasmic Region of the Skeletal Muscle Ryanodine ReceptorThe Journal of general physiology, 2001
- Excitation–contraction uncoupling by a human central core disease mutation in the ryanodine receptorProceedings of the National Academy of Sciences, 2001
- A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca 2+ release channel function and severe central core diseaseProceedings of the National Academy of Sciences, 1999
- Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release ChannelsPublished by Elsevier ,1999
- Mutation Screening of the RYR1 Gene in Malignant Hyperthermia: Detection of a Novel Tyr to Ser Mutation in a Pedigree with Associated Central CoresGenomics, 1994
- [3H]PN200-110 and [3H]ryanodine binding and reconstitution of ion channel activity with skeletal muscle membranesAnalytical Biochemistry, 1989